Respiratory syncytial virus (RSV) is a common respiratory virus that usually causes mild symptoms but can be more severe for infants and young children. An estimated 58,000-80,000 children under 5 years old are hospitalized each year in the U.S. due to RSV infection. One preventive option to protect babies from severe RSV is an RSV immunization given to infants and young children. An RSV immunization is different from a typical vaccine because it contains monoclonal antibodies, but it provides protection similar to that of a vaccine.
SB 559 will help ensure that the RSV immunization will be available and accessible for all New Hampshire children in the future.
About the Bill
SB 559 expands the definition of a vaccine under the New Hampshire Vaccine Association law to help ensure that the new RSV immunization for infants will be covered under the Association. The NH Vaccine Association facilitates the universal purchase of vaccines for the children of New Hampshire, making them available to every child regardless of their ability to pay. This bill does not add the RSV immunization to the vaccination schedule, meaning that it remains optional for Granite State families.
Bill Status
The Senate voted to pass SB 559 in late March. On May 23, the House of Representatives passed an amended version of the bill. Since the bill was amended by the House, it was sent back to the Senate for review. On May 30, the Senate voted to concur with the House amendment to SB 559, meaning that it will now advance to the Governor's desk!
.png?resize=360x0)
